Stock 688217 SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Shanghai Rightongene Biotechnology Co., Ltd.

Equities

688217

CNE100005212

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
24.98 CNY +1.13% Intraday chart for Shanghai Rightongene Biotechnology Co., Ltd. -6.09% -30.18%
Apr. 26 Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 29 Shanghai Rightongene Biotechnology Co., Ltd. commences an Equity Buyback Plan for CNY 20 million worth of its shares, under the authorization approved on February 28, 2024. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shanghai Rightongene Biotechnology Co., Ltd. commences an Equity Buyback Plan for CNY 20 million worth of its shares, under the authorization approved on February 28, 2024.
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shanghai Righton Yuntai Biomedical Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Shanghai Rightongene Biotechnology Co., Ltd.
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shanghai Rightongene Biotechnology Co., Ltd.(SHSE:688217) added to Shanghai Stock Exchange A Share Index
CI
Shanghai Rightongene Biotechnology Co., Ltd.(SHSE:688217) added to Shanghai Stock Exchange Composite Index
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688217 Stock
  4. News Shanghai Rightongene Biotechnology Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW